AC-163954

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAC-163954
Drug Alias Namesecond-generation PYY 3-36 analogs (Amylin/Takeda)AC-163954
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionPeptide Tyrosine Tyrosine modulators
TargetsPeptide Tyrosine Tyrosine
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmylin Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsObesity

Other Information

ATC CodeN/A
Related LinksN/A